Dow Up 0.25% Nasdaq Up 0.65%

T. Rowe Price Health Sciences (PRHSX)

63.29 Up 0.48(0.76%) May 27
Prev Close:62.81
YTD Return*:-10.70%
Net Assets*:11.80B
Yield*:N/A

* As of 30-Apr-16

Quotes delayed, except where indicated otherwise. Currency in USD.

Top Holdings

Symbol% AssetsYTD Return %
AGN6.17N/A
HUM4.59N/A
UNH4.56N/A
ALXN4.03N/A
AET3.95N/A

Fund Basics

Morningstar Overall Rating:
Total Assets:11.8B
Category:Health
Annual Report Expense Ratio (net):0.76%

Performance & Risk

YTD Return:-10.70%
5y Avg Return:20.01%
Rank in Category (ytd):74
% Rank in Category (ytd):57.81%
Beta (3y):0.84
Morningstar Risk Rating:4

Fund Summary

The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback